{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:04:41Z","timestamp":1790283881212,"version":"4.1.0"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,24]]},"DOI":"10.7759\/cureus.116859","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:51:04Z","timestamp":1790283064000},"source":"Crossref","is-referenced-by-count":0,"title":["Psoriasis and Psoriatic Arthritis in Pregnancy: Current Evidence and Clinical Considerations"],"prefix":"10.7759","author":[{"given":"Anna","family":"Paczkowska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Danieluk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Glinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Adamaszek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kinga","family":"Grabowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksander","family":"Gawda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agata","family":"Nawrocka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/medicina57080804","article-title":"State-of-the-art review of pregnancy-related psoriasis","volume":"57","author":"Simionescu AA","year":"2021","unstructured":"Simionescu AA, Danciu BM, Stanescu AM. State-of-the-art review of pregnancy-related psoriasis. Medicina (Kaunas). 2021, 57:804. 10.3390\/medicina57080804","journal-title":"Medicina (Kaunas)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m1590","article-title":"National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study","volume":"369","author":"Parisi R","year":"2020","unstructured":"Parisi R, Iskandar IY, Kontopantelis E, Augustin M, Griffiths CE, Ashcroft DM. National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study. BMJ. 2020, 369:1590. 10.1136\/bmj.m1590","journal-title":"BMJ"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/medicina58060780","article-title":"Oversight and management of women with psoriasis in childbearing age","volume":"58","author":"Bucur \u0218","year":"2022","unstructured":"Bucur \u0218, Savu AP, St\u0103nescu AM, et al.. Oversight and management of women with psoriasis in childbearing age. Medicina (Kaunas). 2022, 58:780. 10.3390\/medicina58060780","journal-title":"Medicina (Kaunas)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.12641","article-title":"Psoriasis in those planning a family, pregnant or breast-feeding. The Australasian Psoriasis Collaboration","volume":"59","author":"Rademaker M","year":"2018","unstructured":"Rademaker M, Agnew K, Andrews M, et al.. Psoriasis in those planning a family, pregnant or breast-feeding. The Australasian Psoriasis Collaboration. Australas J Dermatol. 2018, 59:86-100. 10.1111\/ajd.12641","journal-title":"Australas J Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics17010056","article-title":"Pathophysiology and treatment of psoriasis: from clinical practice to basic research","volume":"17","author":"Gao Y","year":"2025","unstructured":"Gao Y, Xu T, Wang Y, Hu Y, Yin S, Qin Z, Yu H. Pathophysiology and treatment of psoriasis: from clinical practice to basic research. Pharmaceutics. 2025, 17:56. 10.3390\/pharmaceutics17010056","journal-title":"Pharmaceutics"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2012.08.015","article-title":"Psoriasis and metabolic syndrome: a systematic review and meta-analysis of observational studies","volume":"68","author":"Armstrong AW","year":"2013","unstructured":"Armstrong AW, Harskamp CT, Armstrong EJ. Psoriasis and metabolic syndrome: a systematic review and meta-analysis of observational studies. J Am Acad Dermatol. 2013, 68:654-62. 10.1016\/j.jaad.2012.08.015","journal-title":"J Am Acad Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32549-6","article-title":"Psoriasis","volume":"397","author":"Griffiths CE","year":"2021","unstructured":"Griffiths CE, Armstrong AW, Gudjonsson JE, Barker JN. Psoriasis. Lancet. 2021, 397:1301-15. 10.1016\/S0140-6736(20)32549-6","journal-title":"Lancet"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)30830-4","article-title":"The pathogenesis of psoriatic arthritis","volume":"391","author":"Veale DJ","year":"2018","unstructured":"Veale DJ, Fearon U. The pathogenesis of psoriatic arthritis. Lancet. 2018, 391:2273-84. 10.1016\/S0140-6736(18)30830-4","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61909-7","article-title":"Psoriasis","volume":"386","author":"Boehncke WH","year":"2015","unstructured":"Boehncke WH, Sch\u00f6n MP. Psoriasis. Lancet. 2015, 386:983-94. 10.1016\/S0140-6736(14)61909-7","journal-title":"Lancet"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2021.04.003","article-title":"Pregnancy in women with psoriatic arthritis: a systematic literature review of disease activity and adverse pregnancy outcomes","volume":"51","author":"Meissner Y","year":"2021","unstructured":"Meissner Y, Rudi T, Fischer-Betz R, Strangfeld A. Pregnancy in women with psoriatic arthritis: a systematic literature review of disease activity and adverse pregnancy outcomes. Semin Arthritis Rheum. 2021, 51:530-8. 10.1016\/j.semarthrit.2021.04.003","journal-title":"Semin Arthritis Rheum"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/ddg.14789","article-title":"Therapy of psoriasis during pregnancy and breast-feeding","volume":"20","author":"Balakirski G","year":"2022","unstructured":"Balakirski G, Gerdes S, Beissert S, Ochsendorf F, von Kiedrowski R, Wilsmann-Theis D. Therapy of psoriasis during pregnancy and breast-feeding. J Dtsch Dermatol Ges. 2022, 20:653-83. 10.1111\/ddg.14789","journal-title":"J Dtsch Dermatol Ges"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14547","article-title":"Psoriasis and adverse pregnancy outcomes: a systematic review of observational studies","volume":"175","author":"Bobotsis R","year":"2016","unstructured":"Bobotsis R, Gulliver WP, Monaghan K, Lynde C, Fleming P. Psoriasis and adverse pregnancy outcomes: a systematic review of observational studies. Br J Dermatol. 2016, 175:464-72. 10.1111\/bjd.14547","journal-title":"Br J Dermatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1590\/abd1806-4841.20153113","article-title":"Treatment of psoriasis and psoriatic arthritis during pregnancy and breastfeeding","volume":"90","author":"Kurizky PS","year":"2015","unstructured":"Kurizky PS, Ferreira Cde C, Nogueira LS, Mota LM. Treatment of psoriasis and psoriatic arthritis during pregnancy and breastfeeding. An Bras Dermatol. 2015, 90:367-75. 10.1590\/abd1806-4841.20153113","journal-title":"An Bras Dermatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1728-4465.2014.00393.x","article-title":"Intended and unintended pregnancies worldwide in 2012 and recent trends","volume":"45","author":"Sedgh G","year":"2014","unstructured":"Sedgh G, Singh S, Hussain R. Intended and unintended pregnancies worldwide in 2012 and recent trends. Stud Fam Plann. 2014, 45:301-14. 10.1111\/j.1728-4465.2014.00393.x","journal-title":"Stud Fam Plann"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20061475","article-title":"Psoriasis pathogenesis and treatment","volume":"20","author":"Rendon A","year":"2019","unstructured":"Rendon A, Sch\u00e4kel K. Psoriasis pathogenesis and treatment. Int J Mol Sci. 2019, 20:1475. 10.3390\/ijms20061475","journal-title":"Int J Mol Sci"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15382","article-title":"Large scale meta-analysis characterizes genetic architecture for common psoriasis associated variants","volume":"8","author":"Tsoi LC","year":"2017","unstructured":"Tsoi LC, Stuart PE, Tian C, et al.. Large scale meta-analysis characterizes genetic architecture for common psoriasis associated variants. Nat Commun. 2017, 8:15382. 10.1038\/ncomms15382","journal-title":"Nat Commun"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-023-01381-0","article-title":"Triggers for the onset and recurrence of psoriasis: a review and update","volume":"22","author":"Liu S","year":"2024","unstructured":"Liu S, He M, Jiang J, et al.. Triggers for the onset and recurrence of psoriasis: a review and update. Cell Commun Signal. 2024, 22:108. 10.1186\/s12964-023-01381-0","journal-title":"Cell Commun Signal"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0897.2010.00836.x","article-title":"The immune system in pregnancy: a unique complexity","volume":"63","author":"Mor G","year":"2010","unstructured":"Mor G, Cardenas I. The immune system in pregnancy: a unique complexity. Am J Reprod Immunol. 2010, 63:425-33. 10.1111\/j.1600-0897.2010.00836.x","journal-title":"Am J Reprod Immunol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1038\/nri3361","article-title":"Mechanisms of T cell tolerance towards the allogeneic fetus","volume":"13","author":"Erlebacher A","year":"2013","unstructured":"Erlebacher A. Mechanisms of T cell tolerance towards the allogeneic fetus. Nat Rev Immunol. 2013, 13:23-33. 10.1038\/nri3361","journal-title":"Nat Rev Immunol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.23736\/S0392-0488.18.06255-7","article-title":"Moderate-to-severe psoriasis and pregnancy: impact on fertility, pregnancy outcome and treatment perspectives","volume":"154","author":"De Simone C","year":"2019","unstructured":"De Simone C, Caldarola G, Moretta G, Piscitelli L, Ricceri F, Prignano F. Moderate-to-severe psoriasis and pregnancy: impact on fertility, pregnancy outcome and treatment perspectives. G Ital Dermatol Venereol. 2019, 154:305-14. 10.23736\/S0392-0488.18.06255-7","journal-title":"G Ital Dermatol Venereol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.yhbeh.2012.02.023","article-title":"Pregnancy and pregnancy-associated hormones alter immune responses and disease pathogenesis","volume":"62","author":"Robinson DP","year":"2012","unstructured":"Robinson DP, Klein SL. Pregnancy and pregnancy-associated hormones alter immune responses and disease pathogenesis. Horm Behav. 2012, 62:263-71. 10.1016\/j.yhbeh.2012.02.023","journal-title":"Horm Behav"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2017.01.002","article-title":"Psoriatic arthritis disease activity during pregnancy and the first-year postpartum","volume":"46","author":"Polachek A","year":"2017","unstructured":"Polachek A, Li S, Polachek IS, Chandran V, Gladman D. Psoriatic arthritis disease activity during pregnancy and the first-year postpartum. Semin Arthritis Rheum. 2017, 46:740-5. 10.1016\/j.semarthrit.2017.01.002","journal-title":"Semin Arthritis Rheum"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ad.2013.06.005","article-title":"Psoriasis in pregnancy: a review (II)","volume":"105","author":"Ruiz V","year":"2014","unstructured":"Ruiz V, Manubens E, Puig L. Psoriasis in pregnancy: a review (II). Actas Dermosifiliogr. 2014, 105:813-21. 10.1016\/j.ad.2013.06.005","journal-title":"Actas Dermosifiliogr"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-2923","article-title":"Effect of maternal psoriasis on pregnancy and birth outcomes: a population-based cohort study from Denmark and Sweden","volume":"98","author":"Br\u00f6ms G","year":"2018","unstructured":"Br\u00f6ms G, Haerskjold A, Granath F, Kieler H, Pedersen L, Berglind IA. Effect of maternal psoriasis on pregnancy and birth outcomes: a population-based cohort study from Denmark and Sweden. Acta Derm Venereol. 2018, 98:728-34. 10.2340\/00015555-2923","journal-title":"Acta Derm Venereol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-208840","article-title":"The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation","volume":"75","author":"G\u00f6testam Skorpen C","year":"2016","unstructured":"G\u00f6testam Skorpen C, Hoeltzenbein M, Tincani A, et al.. The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation. Ann Rheum Dis. 2016, 75:795-810. 10.1136\/annrheumdis-2015-208840","journal-title":"Ann Rheum Dis"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab357","article-title":"Maternal and neonatal outcomes in pregnant women with psoriasis and psoriatic arthritis: a systematic review and meta-analysis","volume":"60","author":"Xie W","year":"2021","unstructured":"Xie W, Huang H, Ji L, Zhang Z. Maternal and neonatal outcomes in pregnant women with psoriasis and psoriatic arthritis: a systematic review and meta-analysis. Rheumatology (Oxford). 2021, 60:4018-28. 10.1093\/rheumatology\/keab357","journal-title":"Rheumatology (Oxford)"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.17219\/acem\/69804","article-title":"The reliability of three psoriasis assessment tools: Psoriasis area and severity index, body surface area and physician global assessment","volume":"26","author":"Bo\u017cek A","year":"2017","unstructured":"Bo\u017cek A, Reich A. The reliability of three psoriasis assessment tools: Psoriasis area and severity index, body surface area and physician global assessment. Adv Clin Exp Med. 2017, 26:851-6. 10.17219\/acem\/69804","journal-title":"Adv Clin Exp Med"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.5114\/dr.2020.95258","article-title":"Psoriasis. Diagnostic and therapeutic recommendations of the Polish Dermatological Society. Part 1","volume":"107","author":"Reich A","year":"2020","unstructured":"Reich A, Adamski Z, Chodorowska G, et al.. Psoriasis. Diagnostic and therapeutic recommendations of the Polish Dermatological Society. Part 1. Dermatol Rev\/Przegl Dermatol. 2020, 107:92-108. 10.5114\/dr.2020.95258","journal-title":"Dermatol Rev\/Przegl Dermatol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1002\/acr.25396","article-title":"Comparing Dapsa, Dapsa28, and DAS28-CRP in patients with psoriatic arthritis initiating a first tumor necrosis factor inhibitor across nine European countries","volume":"76","author":"Linde L","year":"2024","unstructured":"Linde L, Georgiadis S, \u00d8rnbjerg LM, et al.. Comparing Dapsa, Dapsa28, and DAS28-CRP in patients with psoriatic arthritis initiating a first tumor necrosis factor inhibitor across nine European countries. Arthritis Care Res (Hoboken). 2024, 76:1558-65. 10.1002\/acr.25396","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.5826\/dpc.1404a221","article-title":"Impact of psoriasis on pregnancy desire and possible consequences on fertility","volume":"14","author":"Burlando M","year":"2024","unstructured":"Burlando M, Salvi I, Poddine G, Cozzani E, Parodi A. Impact of psoriasis on pregnancy desire and possible consequences on fertility. Dermatol Pract Concept. 2024, 14:2024221. 10.5826\/dpc.1404a221","journal-title":"Dermatol Pract Concept"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1177\/1753495X18820463","article-title":"Pregnancy outcomes, fertility, and family planning in women with psoriatic arthritis","volume":"13","author":"Eudy AM","year":"2020","unstructured":"Eudy AM, McDaniel G, Clowse ME. Pregnancy outcomes, fertility, and family planning in women with psoriatic arthritis. Obstet Med. 2020, 13:70-5. 10.1177\/1753495X18820463","journal-title":"Obstet Med"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.tjog.2018.02.010","article-title":"Diminished ovarian reserve in patients with psoriasis","volume":"57","author":"Tu\u011frul Ayano\u011flu B","year":"2018","unstructured":"Tu\u011frul Ayano\u011flu B, \u00d6zdemir ED, T\u00fcrko\u011flu O, Alhan A. Diminished ovarian reserve in patients with psoriasis. Taiwan J Obstet Gynecol. 2018, 57:227-30. 10.1016\/j.tjog.2018.02.010","journal-title":"Taiwan J Obstet Gynecol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.18164","article-title":"Women with moderate-to-severe psoriasis in Spain (BIOBADADERM registry) show more than a 50% reduction in age-adjusted fertility rate when compared with the general population","volume":"181","author":"Gonzalez-Cantero A","year":"2019","unstructured":"Gonzalez-Cantero A, Carretero G, Rivera R, et al.. Women with moderate-to-severe psoriasis in Spain (BIOBADADERM registry) show more than a 50% reduction in age-adjusted fertility rate when compared with the general population. Br J Dermatol. 2019, 181:1085-7. 10.1111\/bjd.18164","journal-title":"Br J Dermatol"},{"key":"ref34","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2019.05.099","article-title":"Reproductive patterns and maternal and pregnancy outcomes in women with psoriasis\u2014a population-based study","volume":"82","author":"Lambe M","year":"2020","unstructured":"Lambe M, Bergstr\u00f6m A, Johansson ALV, Weibull CE. Reproductive patterns and maternal and pregnancy outcomes in women with psoriasis\u2014a population-based study. J Am Acad Dermatol. 2020, 82:1109-16.","journal-title":"J Am Acad Dermatol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1159\/000471849","article-title":"Untreated psoriasis impairs male fertility: a case-control study","volume":"233","author":"Caldarola G","year":"2017","unstructured":"Caldarola G, Milardi D, Grande G, et al.. Untreated psoriasis impairs male fertility: a case-control study. Dermatology. 2017, 233:170-4. 10.1159\/000471849","journal-title":"Dermatology"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000044758","article-title":"The causal effect between psoriasis and male reproductive health, and the mediating effect of serum inflammatory factors and metabolites","volume":"104","author":"Ma S","year":"2025","unstructured":"Ma S, Ma R, Zhang Y, et al.. The causal effect between psoriasis and male reproductive health, and the mediating effect of serum inflammatory factors and metabolites. Medicine (Baltimore). 2025, 104:44758. 10.1097\/MD.0000000000044758","journal-title":"Medicine (Baltimore)"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1002\/acr.24130","article-title":"2020 American College of Rheumatology Guideline for the management of reproductive health in rheumatic and musculoskeletal diseases","volume":"72","author":"Sammaritano LR","year":"2020","unstructured":"Sammaritano LR, Bermas BL, Chakravarty EE, et al.. 2020 American College of Rheumatology Guideline for the management of reproductive health in rheumatic and musculoskeletal diseases. Arthritis Care Res (Hoboken). 2020, 72:461-88. 10.1002\/acr.24130","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ard.2025.02.023","article-title":"EULAR recommendations for use of antirheumatic drugs in reproduction, pregnancy, and lactation: 2024 update","volume":"84","author":"R\u00fcegg L","year":"2025","unstructured":"R\u00fcegg L, Pluma A, Hamroun S, et al.. EULAR recommendations for use of antirheumatic drugs in reproduction, pregnancy, and lactation: 2024 update. Ann Rheum Dis. 2025, 84:910-26. 10.1016\/j.ard.2025.02.023","journal-title":"Ann Rheum Dis"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2021.03.020","article-title":"Paternal exposure to immunosuppressive and\/or biologic agents and birth outcomes in patients with immune-mediated inflammatory diseases","volume":"161","author":"Meserve J","year":"2021","unstructured":"Meserve J, Luo J, Zhu W, et al.. Paternal exposure to immunosuppressive and\/or biologic agents and birth outcomes in patients with immune-mediated inflammatory diseases. Gastroenterology. 2021, 161:107-115.e3. 10.1053\/j.gastro.2021.03.020","journal-title":"Gastroenterology"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-024-01153-w","article-title":"Male fertility in spondyloarthritis: from clinical issues to cytokines milieu. A narrative review","volume":"26","author":"Scriffignano S","year":"2024","unstructured":"Scriffignano S, Perrotta FM, Lubrano E. Male fertility in spondyloarthritis: from clinical issues to cytokines milieu. A narrative review. Curr Rheumatol Rep. 2024, 26:321-31. 10.1007\/s11926-024-01153-w","journal-title":"Curr Rheumatol Rep"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2010.02.005","article-title":"Psoriasis and pregnancy outcomes: a nationwide population-based study","volume":"64","author":"Yang YW","year":"2011","unstructured":"Yang YW, Chen CS, Chen YH, Lin HC. Psoriasis and pregnancy outcomes: a nationwide population-based study. J Am Acad Dermatol. 2011, 64:71-7. 10.1016\/j.jaad.2010.02.005","journal-title":"J Am Acad Dermatol"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2010.03917.x","article-title":"Pregnancy outcomes in women with moderate-to-severe psoriasis","volume":"25","author":"Cohen-Barak E","year":"2011","unstructured":"Cohen-Barak E, Nachum Z, Rozenman D, Ziv M. Pregnancy outcomes in women with moderate-to-severe psoriasis. J Eur Acad Dermatol Venereol. 2011, 25:1041-7. 10.1111\/j.1468-3083.2010.03917.x","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref43","article-title":"Pregnancy outcome in women with psoriasis","volume":"53","author":"Ben-David G","year":"2008","unstructured":"Ben-David G, Sheiner E, Hallak M, Levy A. Pregnancy outcome in women with psoriasis. J Reprod Med. 2008, 53:183-7.","journal-title":"J Reprod Med"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2011.271","article-title":"The impact of psoriasis on pregnancy outcomes","volume":"132","author":"Lima XT","year":"2012","unstructured":"Lima XT, Janakiraman V, Hughes MD, Kimball AB. The impact of psoriasis on pregnancy outcomes. J Invest Dermatol. 2012, 132:85-91. 10.1038\/jid.2011.271","journal-title":"J Invest Dermatol"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2010.09899.x","article-title":"Potentially modifiable risk factors for adverse pregnancy outcomes in women with psoriasis","volume":"163","author":"Bandoli G","year":"2010","unstructured":"Bandoli G, Johnson DL, Jones KL, et al.. Potentially modifiable risk factors for adverse pregnancy outcomes in women with psoriasis. Br J Dermatol. 2010, 163:334-9. 10.1111\/j.1365-2133.2010.09899.x","journal-title":"Br J Dermatol"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.19193","article-title":"Folic acid supplementation for the prevention of neural tube defects: an updated evidence report and systematic review for the US Preventive Services Task Force","volume":"317","author":"Viswanathan M","year":"2017","unstructured":"Viswanathan M, Treiman KA, Kish-Doto J, Middleton JC, Coker-Schwimmer EJ, Nicholson WK. Folic acid supplementation for the prevention of neural tube defects: an updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2017, 317:190-203. 10.1001\/jama.2016.19193","journal-title":"JAMA"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-025-07766-5","article-title":"A clinical care pathway for managing pregnancy in patients with inflammatory arthritis","volume":"45","author":"Amiri N","year":"2026","unstructured":"Amiri N, Gamble M, Laskin C, Pavlova V, Troster S. A clinical care pathway for managing pregnancy in patients with inflammatory arthritis. Clin Rheumatol. 2026, 45:13-28. 10.1007\/s10067-025-07766-5","journal-title":"Clin Rheumatol"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-3384","article-title":"Psoriasis and genetics","volume":"100","author":"Dand N","year":"2020","unstructured":"Dand N, Mahil SK, Capon F, Smith CH, Simpson MA, Barker JN. Psoriasis and genetics. Acta Derm Venereol. 2020, 100:00030. 10.2340\/00015555-3384","journal-title":"Acta Derm Venereol"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9080940","article-title":"Pediatric psoriasis: From new insights into pathogenesis to updates on treatment","volume":"9","author":"Kim HO","year":"2021","unstructured":"Kim HO, Kang SY, Kim JC, Park CW, Chung BY. Pediatric psoriasis: From new insights into pathogenesis to updates on treatment. Biomedicines. 2021, 9:940. 10.3390\/biomedicines9080940","journal-title":"Biomedicines"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2023.07.003","article-title":"Genetic studies investigating susceptibility to psoriatic arthritis: a narrative review","volume":"45","author":"Soomro M","year":"2023","unstructured":"Soomro M, Hum R, Barton A, Bowes J. Genetic studies investigating susceptibility to psoriatic arthritis: a narrative review. Clin Ther. 2023, 45:810-5. 10.1016\/j.clinthera.2023.07.003","journal-title":"Clin Ther"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12375","article-title":"Heritability of psoriasis in a large twin sample","volume":"169","author":"L\u00f8nnberg AS","year":"2013","unstructured":"L\u00f8nnberg AS, Skov L, Skytthe A, Kyvik KO, Pedersen OB, Thomsen SF. Heritability of psoriasis in a large twin sample. Br J Dermatol. 2013, 169:412-6. 10.1111\/bjd.12375","journal-title":"Br J Dermatol"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.3390\/biom14050548","article-title":"Functional genomics and insights into the pathogenesis and treatment of psoriasis","volume":"14","author":"Shellard EM","year":"2024","unstructured":"Shellard EM, Rane SS, Eyre S, Warren RB. Functional genomics and insights into the pathogenesis and treatment of psoriasis. Biomolecules. 2024, 14:10. 10.3390\/biom14050548","journal-title":"Biomolecules"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.4006","article-title":"Pathophysiology, clinical presentation, and treatment of psoriasis: a review","volume":"323","author":"Armstrong AW","year":"2020","unstructured":"Armstrong AW, Read C. Pathophysiology, clinical presentation, and treatment of psoriasis: a review. JAMA. 2020, 323:1945-60. 10.1001\/jama.2020.4006","journal-title":"JAMA"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1016\/j.ad.2020.10.002","article-title":"Management of psoriasis during preconception, pregnancy, postpartum, and breastfeeding: a consensus statement","volume":"112","author":"Belinch\u00f3n I","year":"2021","unstructured":"Belinch\u00f3n I, Velasco M, Ara-Mart\u00edn M, et al.. Management of psoriasis during preconception, pregnancy, postpartum, and breastfeeding: a consensus statement. Actas Dermosifiliogr (Engl Ed). 2021, 112:225-41. 10.1016\/j.ad.2020.10.002","journal-title":"Actas Dermosifiliogr (Engl Ed)"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.70818\/bmcj.v011i2.0259","article-title":"Quality of life and psychological burden among pregnant women living with psoriasis: a cross-sectional study of 120 cases","volume":"11","author":"Dey P","year":"2025","unstructured":"Dey P, Nath SK, Arman YJ, Al Faisal A, Sarker SC. Quality of life and psychological burden among pregnant women living with psoriasis: a cross-sectional study of 120 cases. Barind Medical College J. 2025, 11:189-203. 10.70818\/bmcj.v011i2.0259","journal-title":"Barind Medical College J"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2013.508","article-title":"The prevalence and odds of depressive symptoms and clinical depression in psoriasis patients: a systematic review and meta-analysis","volume":"134","author":"Dowlatshahi EA","year":"2014","unstructured":"Dowlatshahi EA, Wakkee M, Arends LR, Nijsten T. The prevalence and odds of depressive symptoms and clinical depression in psoriasis patients: a systematic review and meta-analysis. J Invest Dermatol. 2014, 134:1542-51. 10.1038\/jid.2013.508","journal-title":"J Invest Dermatol"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.130797","article-title":"Depression and anxiety in psoriatic disease: prevalence and associated factors","volume":"41","author":"McDonough E","year":"2014","unstructured":"McDonough E, Ayearst R, Eder L, Chandran V, Rosen CF, Thavaneswaran A, Gladman DD. Depression and anxiety in psoriatic disease: prevalence and associated factors. J Rheumatol. 2014, 41:887-96. 10.3899\/jrheum.130797","journal-title":"J Rheumatol"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200104)45:2<151::AID-ANR168>3.0.CO;2-T","article-title":"Health-related quality of life of patients with psoriatic arthritis: a comparison with patients with rheumatoid arthritis","volume":"45","author":"Husted JA","year":"2001","unstructured":"Husted JA, Gladman DD, Farewell VT, Cook RJ. Health-related quality of life of patients with psoriatic arthritis: a comparison with patients with rheumatoid arthritis. Arthritis Rheum. 2001, 45:151-8. 10.1002\/1529-0131(200104)45:2&lt;151::AID-ANR168&gt;3.0.CO;2-T","journal-title":"Arthritis Rheum"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-1273","article-title":"Living with psoriasis: prevalence of shame, anger, worry, and problems in daily activities and social life","volume":"92","author":"Sampogna F","year":"2012","unstructured":"Sampogna F, Tabolli S, Abeni D. Living with psoriasis: prevalence of shame, anger, worry, and problems in daily activities and social life. Acta Derm Venereol. 2012, 92:299-303. 10.2340\/00015555-1273","journal-title":"Acta Derm Venereol"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijwd.2019.04.021","article-title":"Clinical considerations for the management of psoriasis in women","volume":"5","author":"Gottlieb AB","year":"2019","unstructured":"Gottlieb AB, Ryan C, Murase JE. Clinical considerations for the management of psoriasis in women. Int J Womens Dermatol. 2019, 5:141-50. 10.1016\/j.ijwd.2019.04.021","journal-title":"Int J Womens Dermatol"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.19039","article-title":"British Association of Dermatologists guidelines for biologic therapy for psoriasis 2020: a rapid update","volume":"183","author":"Smith CH","year":"2020","unstructured":"Smith CH, Yiu ZZ, Bale T, et al.. British Association of Dermatologists guidelines for biologic therapy for psoriasis 2020: a rapid update. Br J Dermatol. 2020, 183:628-37. 10.1111\/bjd.19039","journal-title":"Br J Dermatol"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.5114\/dr.2020.95259","article-title":"Psoriasis. Diagnostic and therapeutic recommendations of the Polish Dermatological Society. Part 2","volume":"107","author":"Reich A","year":"2020","unstructured":"Reich A, Adamski Z, Chodorowska G, et al.. Psoriasis. Diagnostic and therapeutic recommendations of the Polish Dermatological Society. Part 2. Dermatol Rev. 2020, 107:110-37. 10.5114\/dr.2020.95259","journal-title":"Dermatol Rev"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.7573\/dic.2019-11-6","article-title":"Management of psoriasis in pregnancy - a review of the evidence to date","volume":"9","author":"Ferreira C","year":"2020","unstructured":"Ferreira C, Azevedo A, Nogueira M, Torres T. Management of psoriasis in pregnancy - a review of the evidence to date. Drugs Context. 2020, 9:2019-11. 10.7573\/dic.2019-11-6","journal-title":"Drugs Context"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2023.10.072","article-title":"Safety of dermatologic medications in pregnancy and lactation: an update - part I: pregnancy","volume":"91","author":"McMullan P","year":"2024","unstructured":"McMullan P, Yaghi M, Truong TM, Rothe M, Murase J, Grant-Kels JM. Safety of dermatologic medications in pregnancy and lactation: an update - part I: pregnancy. J Am Acad Dermatol. 2024, 91:619-48. 10.1016\/j.jaad.2023.10.072","journal-title":"J Am Acad Dermatol"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2021.1090","article-title":"Evaluation of topical corticosteroid use in pregnancy and risk of newborns being small for gestational age and having low birth weight","volume":"157","author":"Andersson NW","year":"2021","unstructured":"Andersson NW, Skov L, Andersen JT. Evaluation of topical corticosteroid use in pregnancy and risk of newborns being small for gestational age and having low birth weight. JAMA Dermatol. 2021, 157:788-95. 10.1001\/jamadermatol.2021.1090","journal-title":"JAMA Dermatol"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1016\/j.ard.2025.02.021","article-title":"Antirheumatic drugs in reproduction, pregnancy, and lactation: a systematic literature review informing the 2024 update of the EULAR recommendations","volume":"84","author":"Pluma A","year":"2025","unstructured":"Pluma A, Hamroun S, R\u00fcegg L, et al.. Antirheumatic drugs in reproduction, pregnancy, and lactation: a systematic literature review informing the 2024 update of the EULAR recommendations. Ann Rheum Dis. 2025, 84:1561-90. 10.1016\/j.ard.2025.02.021","journal-title":"Ann Rheum Dis"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211384","article-title":"Minimal to no transfer of certolizumab pegol into breast milk: results from CRADLE, a prospective, postmarketing, multicentre, pharmacokinetic study","volume":"76","author":"Clowse ME","year":"2017","unstructured":"Clowse ME, F\u00f6rger F, Hwang C, et al.. Minimal to no transfer of certolizumab pegol into breast milk: results from CRADLE, a prospective, postmarketing, multicentre, pharmacokinetic study. Ann Rheum Dis. 2017, 76:1890-6. 10.1136\/annrheumdis-2017-211384","journal-title":"Ann Rheum Dis"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-212196","article-title":"Lack of placental transfer of certolizumab pegol during pregnancy: results from CRIB, a prospective, postmarketing, pharmacokinetic study","volume":"77","author":"Mariette X","year":"2018","unstructured":"Mariette X, F\u00f6rger F, Abraham B, et al.. Lack of placental transfer of certolizumab pegol during pregnancy: results from CRIB, a prospective, postmarketing, pharmacokinetic study. Ann Rheum Dis. 2018, 77:228-33. 10.1136\/annrheumdis-2017-212196","journal-title":"Ann Rheum Dis"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keac551","article-title":"British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids","volume":"62","author":"Russell MD","year":"2023","unstructured":"Russell MD, Dey M, Flint J, et al.. British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids. Rheumatology (Oxford). 2023, 62:48-88. 10.1093\/rheumatology\/keac551","journal-title":"Rheumatology (Oxford)"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1159\/000542217","article-title":"Biologics use for psoriasis during pregnancy and its related adverse outcomes in pregnant women and newborns: findings from who pharmacovigilance study","volume":"186","author":"Jeong YD","year":"2025","unstructured":"Jeong YD, Jo H, Cho H, et al.. Biologics use for psoriasis during pregnancy and its related adverse outcomes in pregnant women and newborns: findings from who pharmacovigilance study. Int Arch Allergy Immunol. 2025, 186:579-93. 10.1159\/000542217","journal-title":"Int Arch Allergy Immunol"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-023-01314-2","article-title":"Use of acitretin among girls and women of childbearing age and occurrence of acitretin-exposed pregnancies in Germany","volume":"43","author":"Reinold J","year":"2023","unstructured":"Reinold J, Kollhorst B, Temme HL, Wentzell N, Haug U. Use of acitretin among girls and women of childbearing age and occurrence of acitretin-exposed pregnancies in Germany. Clin Drug Investig. 2023, 43:865-72. 10.1007\/s40261-023-01314-2","journal-title":"Clin Drug Investig"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16926","article-title":"Euroguiderm guideline on the systemic treatment of psoriasis vulgaris - part 2: specific clinical and comorbid situations","volume":"35","author":"Nast A","year":"2021","unstructured":"Nast A, Smith C, Spuls PI, et al.. Euroguiderm guideline on the systemic treatment of psoriasis vulgaris - part 2: specific clinical and comorbid situations. J Eur Acad Dermatol Venereol. 2021, 35:281-317. 10.1111\/jdv.16926","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.5114\/ada.2020.102089","article-title":"The use of biological drugs in psoriasis patients prior to pregnancy, during pregnancy and lactation: a review of current clinical guidelines","volume":"37","author":"Owczarek W","year":"2020","unstructured":"Owczarek W, Walecka I, Lesiak A, Czajkowski R, Reich A, Zerda I, Narbutt J. The use of biological drugs in psoriasis patients prior to pregnancy, during pregnancy and lactation: a review of current clinical guidelines. Postepy Dermatol Alergol. 2020, 37:821-30. 10.5114\/ada.2020.102089","journal-title":"Postepy Dermatol Alergol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/530765-psoriasis-and-psoriatic-arthritis-in-pregnancy-current-evidence-and-clinical-considerations","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:51:06Z","timestamp":1790283066000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/530765-psoriasis-and-psoriatic-arthritis-in-pregnancy-current-evidence-and-clinical-considerations"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,24]]},"references-count":73,"URL":"https:\/\/doi.org\/10.7759\/cureus.116859","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,24]]}}}